| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| halothane | plasma membrane calcium-transporting atpase | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | inhibitor |
| halothane | plasma membrane calcium-transporting atpase | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | inhibitor |
| halothane | plasma membrane calcium-transporting atpase | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | inhibitor |
| halothane | plasma membrane calcium-transporting atpase | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | inhibitor |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.11 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gamma-aminobutyric acid receptor subunit alpha-1 | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.11 | approved,vet_approved | positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.02 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.02 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.04 | approved,vet_approved | positive allosteric modulator,positive modulator |
| halothane | glycine receptor subunit alpha-1 | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.39 | approved,vet_approved | allosteric modulator |
| halothane | guanine nucleotide-binding protein g(i)/g(s)/g(o) subunit gamma-2 | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | unknown |
| halothane | glutamate receptor ionotropic, nmda 2a | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | antagonist |
| halothane | glutamate receptor ionotropic, nmda 3a | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | antagonist |
| halothane | glutamate receptor ionotropic, nmda 3b | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | antagonist |
| halothane | g protein-activated inward rectifier potassium channel 1 | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | inhibitor |
| halothane | g protein-activated inward rectifier potassium channel 2 | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | inhibitor |
| halothane | potassium channel subfamily k member 3 | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.03 | approved,vet_approved | binder,activator |
| halothane | potassium channel subfamily k member 3 | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.03 | approved,vet_approved | binder |
| halothane | potassium channel subfamily k member 9 | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.17 | approved,vet_approved | binder,activator |
| halothane | potassium channel subfamily k member 9 | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.17 | approved,vet_approved | binder |
| halothane | calcium-activated potassium channel subunit alpha-1 | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | inhibitor |
| halothane | intermediate conductance calcium-activated potassium channel protein 4 | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | inhibitor |
| halothane | nadh-ubiquinone oxidoreductase chain 1 | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | inhibitor |
| halothane | neuropeptide s receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | unknown |
| halothane | rhodopsin | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | other |
| click here to return to the previous page | ||||||||